Strategic Partnerships Momentum Tecan is actively forming high-visibility partnerships with industry players such as HP for the Duo Digital Dispenser, and collaborating with BioSkryb for high-throughput single-cell sequencing workflows, as well as CUTISS in tissue therapeutics. These alliances signal opportunities to co-sell integrated automation solutions and to win multi-vendor deals across biotech, diagnostics, and regenerative medicine verticals.

Single-Cell Genomics Demand Recent partnerships and product launches emphasize growing demand for scalable single-cell and high-throughput workflows. Tecan’s Veya liquid handling platform supports efficient, precise, and compliant automation for labs of all sizes, making it a strong candidate to upsell to genomics and translational research customers.

Scalable Automation Platform Veya positions Tecan to serve a broad lab audience—from academic labs to biotech and pharma—while enterprise IT readiness (SAP ERP, SAP S/4HANA and SuccessFactors) enables seamless procurement, deployment, and global service. This creates opportunities for multi-site automation deployments and managed services.

Vertical Market Expansion Active engagement with diverse partners across biotech, tissue engineering, and diagnostics suggests room to expand into additional verticals such as cell therapy, regenerative medicine, and precision diagnostics. Target these ecosystems with co-developed workflows, turnkey solutions, and validated use cases.

Enterprise Capacity With significant scale and a global team, Tecan can pursue large, long-term automation contracts, extensive service agreements, and worldwide support packages, making it a strong partner for multinational labs and contract research organizations.